Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.
about
Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.Mechanisms of Regulation of the Chemokine-Receptor Network.Pyroglutamate-Modified Amyloid β (11- 40) Fibrils Are More Toxic than Wildtype Fibrils but Structurally Very Similar.Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study
P2860
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@ast
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@en
type
label
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@ast
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@en
prefLabel
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@ast
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@en
P2093
P2860
P1476
Isoglutaminyl cyclase contribu ...... mation in Alzheimer's disease.
@en
P2093
Alexander Waniek
Astrid Kehlen
Carsten Jäger
Hans-Ulrich Demuth
Maike Hartlage-Rübsamen
Markus Morawski
Martin Kleinschmidt
Steffen Rossner
Stephan Schilling
Thomas Arendt
P2860
P2888
P304
P356
10.1007/S00401-015-1395-2
P577
2015-02-11T00:00:00Z